Cetera Investment Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Cetera Investment Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,937	Closed	-$240K	–	4965
2025 Q4	$240K	Sell	10,937 -2,992	-21%	-$54K	﹤0.01%	4098
2025 Q3	$169K	Sell	13,929 -794	-5%	-$10.7K	﹤0.01%	4194
2025 Q2	$274K	Sell	14,723 -3,977	-21%	-$78.8K	﹤0.01%	3474
2025 Q1	$358K	Buy	18,700 +4,515	+32%	+$132K	﹤0.01%	3115
2024 Q4	$511K	Buy	14,185 +981	+7%	+$33.2K	﹤0.01%	2664
2024 Q3	$560K	Buy	13,204 +1,262	+11%	+$53.5K	﹤0.01%	2563
2024 Q2	$481K	Sell	11,942 -2,415	-17%	-$101K	﹤0.01%	2624
2024 Q1	$508K	Buy	+14,357	New	+$385K	﹤0.01%	2592
2022 Q1	–	Sell	-1,465	Closed	-$221K	–	1995
2021 Q4	$221K	Buy	+1,465	New	+$198K	﹤0.01%	1669

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cetera Investment Advisers's TNDM Position: Q1 2026 in Review

Cetera Investment Advisers sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 10,937 shares — an estimated $240K sold.

Cetera Investment Advisers first reported a position in TNDM in Q4 2021 and held it in 9 quarters. The position peaked at $560K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

Cetera Investment Advisers reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
Cetera Investment Advisers sold 10,937 Tandem Diabetes Care shares in Q1 2026, an estimated $240K.
Cetera Investment Advisers first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 9 quarters.
Cetera Investment Advisers's Tandem Diabetes Care position peaked at $560K in Q3 2024.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.